Drugs

Tamoxifen (3)

Pharmacogenomic Information

 

DrugTherapeutic Area*Biomarker†Referenced
Subgroup
Labeling Sections
TamoxifenOncologyF2

Prothrombin 20210A allele positive

Warnings

 

* Therapeutic areas do not necessarily reflect the CDER review division.

† Standard nomenclature is used for genes as per the Human Genome Organization symbol, cytogenetic abnormalities as per the International System for Human Cytogenetic Nomenclature, or other conventions.

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling

 

Page Last Updated: 03/19/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.